If your foot psoriasis symptoms persist, it may be time to consider systemic therapies, meaning medications that enter the bloodstream and work within your body rather than just on the surface.

Psoriasis and ringworm both cause red, ... For instance, there’s athlete’s foot or tinea pedis, jock itch or tinea cruris, and scalp ringworm or tinea capitis. The differences.

Researchers evaluated the efficacy and safety of icotrokinra for treating plaque psoriasis affecting the scalp, genital, and/or hand/foot areas.

Johnson & Johnson (J&J) has reported new data from the Phase III ICONIC-TOTAL trial, which evaluated icotrokinra, an oral peptide, in treating plaque psoriasis (PsO). The randomised clinical trial ...

Among participants with scalp psoriasis, 66% treated with icotrokinra achieved a scalp-specific IGA (ss-IGA) score of 0 or 1 compared with 11% receiving placebo (P <.001).

66% of patients with scalp psoriasis and 77% with genital psoriasis treated with investigational icotrokinra achieved site-specific clear or almost clear skin at Week 16 Icotrokinra continues to ...

Data from icotrokinra ICONIC-TOTAL show 66% of patients with scalp psoriasis and 77% with genital psoriasis achieved site-specific clear or almost clear skin at Week 16 Icotrokinra continues to ...

66% of patients with scalp psoriasis and 77% with genital psoriasis treated with investigational icotrokinra achieved site-specific clear or almost clear skin at Week 16 Icotrokinra continues to ...

Data from icotrokinra ICONIC-TOTAL show 66% of patients with scalp psoriasis and 77% with genital psoriasis achieved site-specific clear or almost clear skin at Week 16 Icotrokinra continues to ...